CDC2-like (CLK) protein kinase inhibition as a novel targeted therapeutic strategy in prostate cancer

Simon Uzor, Sean Porazinski, Ling Li, Bethany Clark, Masahiko Ajiro, Kei lida, Masatoshi Hagiwara, Abdullah I M Alqasem, Claire M Perks, Ian Wilson, Sebastian Oltean*, Michael R. Ladomery

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

24 Downloads (Pure)

Fingerprint

Dive into the research topics of 'CDC2-like (CLK) protein kinase inhibition as a novel targeted therapeutic strategy in prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences